189 related articles for article (PubMed ID: 32068688)
1. Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial.
Trower M; Anderson RA; Ballantyne E; Joffe H; Kerr M; Pawsey S
Menopause; 2020 May; 27(5):498-505. PubMed ID: 32068688
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial.
Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D
JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224
[TBL] [Abstract][Full Text] [Related]
3. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
Hattersley G; Harris AG; Simon JA; Constantine GD
Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
[TBL] [Abstract][Full Text] [Related]
4. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
[TBL] [Abstract][Full Text] [Related]
5. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
[TBL] [Abstract][Full Text] [Related]
6. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.
Cowles VE; Gordi T; Hou SY
Clin Drug Investig; 2012 Sep; 32(9):593-601. PubMed ID: 22775354
[TBL] [Abstract][Full Text] [Related]
8. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.
Elkins GR; Fisher WI; Johnson AK; Carpenter JS; Keith TZ
Menopause; 2013 Mar; 20(3):291-8. PubMed ID: 23435026
[TBL] [Abstract][Full Text] [Related]
9. The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.
Andrikoula M; Baker D; Nesic J; Liao LM; Duka T; Prelevic GM
Climacteric; 2011 Oct; 14(5):544-50. PubMed ID: 21413865
[TBL] [Abstract][Full Text] [Related]
10. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
Simon JA;
Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women.
Wang CC; Cheng KF; Lo WM; Law C; Li L; Leung PC; Chung TK; Haines CJ
Menopause; 2013 Feb; 20(2):223-31. PubMed ID: 22990757
[TBL] [Abstract][Full Text] [Related]
12. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
Hitchcock CL; Prior JC
Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Rowan JP; Simon JA; Speroff L; Ellman H
Clin Ther; 2006 Jun; 28(6):921-32. PubMed ID: 16860174
[TBL] [Abstract][Full Text] [Related]
14. κ Agonists as a novel therapy for menopausal hot flashes.
Oakley AE; Steiner RA; Chavkin C; Clifton DK; Ferrara LK; Reed SD
Menopause; 2015 Dec; 22(12):1328-34. PubMed ID: 25988798
[TBL] [Abstract][Full Text] [Related]
15. Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA).
Santoro N; Waldbaum A; Lederman S; Kroll R; Fraser GL; Lademacher C; Skillern L; Young J; Ramael S
Menopause; 2020 Dec; 27(12):1350-1356. PubMed ID: 32769757
[TBL] [Abstract][Full Text] [Related]
16. A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
Lobo RA; Archer DF; Kagan R; Kaunitz AM; Constantine GD; Pickar JH; Graham S; Bernick B; Mirkin S
Obstet Gynecol; 2018 Jul; 132(1):161-170. PubMed ID: 29889748
[TBL] [Abstract][Full Text] [Related]
17. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.
Loprinzi CL; Qin R; Balcueva EP; Flynn KA; Rowland KM; Graham DL; Erwin NK; Dakhil SR; Jurgens DJ; Burger KN
J Clin Oncol; 2010 Feb; 28(4):641-7. PubMed ID: 19901102
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
19. The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms.
Speroff L; Symons J; Kempfert N; Rowan J;
Menopause; 2000; 7(6):383-90. PubMed ID: 11127760
[TBL] [Abstract][Full Text] [Related]
20. Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
Simon JA; Chandler J; Gottesdiener K; Lazarus N; He W; Rosenberg E; Wagner JA; Denker AE
Menopause; 2014 Sep; 21(9):938-44. PubMed ID: 24569618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
